✦ LIBER ✦

Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s disease

✍ Scribed by Rissman, Robert A.; Trojanowski, John Q.; Shaw, Leslie M.; Aisen, Paul S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors that influence use of plasma bet

✍ Rissman, Robert A.; Donohue, Michael; Moghadam, Setareh; Sun, Chung-Kai; Roe, Al 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 521 KB

Maximizing the Potential of Plasma Amylo

✍ Esther S. Oh; Juan C. Troncoso; Stina M. Fangmark Tucker 📂 Article 📅 2008 🏛 Humana Press Inc 🌐 English ⚖ 355 KB

Changes in plasma amyloid beta in a long

✍ Rembach, Alan; Faux, Noel G.; Watt, Andrew D.; Pertile, Kelly K.; Rumble, Rebecc 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 714 KB

Microbiosensor for Alzheimer’s disease d

✍ Shradha Prabhulkar; Rudolph Piatyszek; John R. Cirrito; Ze-Zhi Wu; Chen-Zhong Li 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

Change in plasma beta-amyloid level afte

✍ Naoyuki Sato; Shuko Takeda; Hisahiro Yu; Atsushi Moriguchi; Hiromi Rakugi; Ryuic 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Amyloid β and APP as biomarkers for Alzh

✍ Henrik Zetterberg; Kaj Blennow; Eric Hanse 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 346 KB